MMP9 and rheumatoid arthritis: The results indicated that 23 targets, including TNF, ALB, TLR4, STAT3, MMP9, IL2, VCAM1, PTGS2, and others, may be the core targets of P. forrestii in the treatment of RA (Figure 3b, Table S4).